Cellebrite DI Sees Q3 Sales $145.000M-$148.000M vs $150.298M Est

Benzinga Newsdesk www.benzinga.com Positive 84.4%

Neg 0% Neu 0% Pos 84.4%

Cellebrite DI (NASDAQ:CLBT) sees Q3 sales of $145.000 million-$148.000 million vs $150.298 million analyst estimate.

Comments

No comments yet. Be the first!